Skip to Main content Skip to Navigation
Journal articles

Perip7lakin is a target for autoimmunity in asthma

Abstract : AbstractThe role of autoimmunity targeting epithelial antigens in asthma has been suggested, in particular in non-atopic and severe asthma. Periplakin, a desmosomal component, is involved in epithelial cohesion and intracellular signaling. We detected anti-periplakin IgG antibodies in 47/260 (18 %) patients with asthma, with no association with severity or atopy. In addition, anti-periplakin IgE antibodies were detected in 12 of 138 tested patients (8.7 %) and were more frequently observed in patients with than without nasal polyposis. This study identifies a new autoimmune epithelial target in asthma. Whether periplakin autoimmunity (both IgG and IgE auto-antibodies) is involved in asthma pathogenesis remains to be studied during the disease course of these patients.
Document type :
Journal articles
Complete list of metadata

Cited literature [11 references]  Display  Hide  Download
Contributor : BMC BMC Connect in order to contact the contributor
Submitted on : Friday, October 7, 2016 - 8:04:03 AM
Last modification on : Saturday, June 25, 2022 - 10:21:57 PM
Long-term archiving on: : Sunday, January 8, 2017 - 12:25:07 PM


Publication funded by an institution



Camille Taillé, Sabine Grootenboer-Mignot, Candice Estellat, Carine Roy, Sophie Ly Ka So, et al.. Perip7lakin is a target for autoimmunity in asthma. Respiratory Research, BioMed Central, 2016, 17 (1), pp.126. ⟨10.1186/s12931-016-0441-5⟩. ⟨inserm-01377406⟩



Record views


Files downloads